Talut Tablet (Tarniflumate)

Adult dose

Administer 370 mg of talniflumate orally 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

This medication should be consulted with a doctor or pharmacist if the patient regularly consumes more than 3 glasses of soju daily, as it poses a risk of gastrointestinal bleeding. This medication may affect the cardiovascular system, increasing the risk of serious thrombotic events such as myocardial infarction or stroke, so patients with cardiovascular diseases or risk factors should be particularly cautious. Additionally, this medication may cause severe gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforation, so elderly patients or those with a history of gastrointestinal diseases should be cautious. Patients with peptic ulcers or those allergic to the ingredients of this medication, as well as those with hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs, should not take this medication. Patients with severely impaired liver or kidney function and women who are pregnant or breastfeeding should not use this medication. Patients with mild to moderate liver, kidney, or heart conditions, elderly patients, or those with specific dye allergies should use this medication cautiously. While taking this medication, symptoms such as nausea, vomiting, diarrhea, abdominal pain, skin rash, or difficulty breathing may occur, so if any of these symptoms arise, immediate consultation with medical personnel is necessary. Regular blood tests and assessments of liver and kidney function should be performed during prolonged use of this medication to check for abnormalities, and treatment may be discontinued based on symptoms. Interactions may occur if taken with other anti-inflammatory medications or specific drugs, so it is important to inform healthcare professionals of any other medications being taken. In the late stages of pregnancy, this medication may be harmful to the fetus, so it should not be used, and breastfeeding mothers should consider discontinuing breastfeeding or the medication due to the possibility of transfer to breast milk. The safety of this medication has not been established for children under 12 years of age, and elderly patients should take it with the minimum dosage cautiously. Finally, this medication should be kept out of the reach of children and should not be transferred to another container.

• Nausea
• vomiting
• photosensitivity
• asthma attack
• general fatigue due to hypotension
• hypersensitivity shock
• diarrhea
• abdominal distension
• constipation
• indigestion

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is recommended to store it in a cool place, at room temperature between 1°C and 30°C.

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle